The modification of serum lipids after acute coronary syndrome and importance in clinical practice
- PMID: 22758629
- PMCID: PMC3322446
- DOI: 10.2174/157340311799960690
The modification of serum lipids after acute coronary syndrome and importance in clinical practice
Abstract
Atherosclerosis is a pathology characterized by low-grade vascular inflammation rather than a mere accumulation of lipids. Inflammation is central at all stages of atherosclerosis. Acute coronary syndrome significantly affects the concentration and composition of the lipids and lipoproteins in plasma. Plasma triglyceride and very low density lipoprotein levels increase, while high density lipoprotein, low density lipoprotein and total cholesterol levels decrease. Early treatment of hyperlipidemia provides potential benefits. However, post-event changes in lipid and lipoproteins lead to delays in the choice of the treatment. This review focuses on the mechanism and the clinical importance of the relevant changes.
References
-
- Dodds C, Mills GL. Influence of myocardial infarction on plasma lipoprotein concentration. Lancet. 1959;i:1160–63. - PubMed
-
- Scandinavian Simvastatin Survival Study group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) Lancet. 1994;344:2383–9. - PubMed
-
- Ferrieres J, Cambou J-P, Cueret P, et al. Effect of early initiation of statins on survival in patients with acute myocardial infarction (the USIC 2000 Registry) Am J Cardiol. 2005;95:486–9. - PubMed
-
- Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495–1504. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
